This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Share |

 

SCCT Industry Relationship Guidelines

 

The Society of Cardiovascular Computed Tomography (SCCT) is the international professional society devoted exclusively to cardiovascular computed tomography (CCT). Our mission is to advocate for and promote research, education and clinical excellence in the use of CCT, with the ultimate aim of improving the quality of cardiovascular medical practice to enhance patient care and outcomes.

To help achieve our mission, SCCT relies on commercial, promotional, and educational funding from industry. The elimination of this funding could harm the scientific and educational activities of SCCT and would force SCCT to raise membership dues and registration fees for meetings, workshops and online educational products, limiting participation from physicians, scientists and allied professionals.

Acknowledging that these relationships may have the potential for actual or perceived bias or conflict of interest, SCCT has established strict ethical standards to protect the credibility of the Society and its members. 

SCCT has put in place safeguards in several areas to prevent industry bias in our activities.

Governance

1. All members of the Board of Directors and committees comply with the SCCT conflict of interest policy.

2. As part of this policy, members of the Board of Directors and committees disclose the absence and presence of their relationships with industry. All meetings of the Board of Directors, committees and task forces begin with a reminder to participants about the SCCT policy and the need to recuse themselves from discussions in which any relationships they have may come into play.

3. All relationships with industry disclosed in compliance with this policy are proactively provided to stakeholders.

 

CME education and guidelines development

1. SCCT does not allow companies to place restrictions or influence the content of CME programs or guidelines documents.

2. SCCT maintains control over CME educational programs, both live and online.

3. SCCT seeks multiple supporters whenever possible to avoid the perception that programs are tied to a specific company.

4. In line with SCCT’s Collection and Resolution of Conflicts of Interest (COI) Policy:

a. All members of the Education Committee, the Annual Scientific Meeting Program Committee, other program planners, session chairs and presenters comply with the SCCT conflict of interest policy. This requires disclosing the absence and presence of their relationships with industry.

b. All relationships with industry disclosed in compliance with this policy are proactively provided to learners.

c. SCCT proactively resolves potential conflicts of interest that may arise from such relationships.

5. Industry support for CME education is proactively disclosed to learners.

 

Advocacy and payer education

SCCT maintains control of its advocacy, paper education and health policy objectives with the following protocols:

1. Advocacy Committee members must disclose all industry relationships and recuse themselves from any activity or discussion which may present a conflict of interest.

2. The SCCT Advocacy Committee identifies and prioritizes specific goals on an annual basis. The recommendations of the committee are then approved by the SCCT Board of Directors.

3. Occasionally the SCCT Advocacy Committee may determine that collaboration with additional stakeholders is needed to achieve advocacy goals.  If industry stakeholders are identified as a possible champion of SCCT advocacy goals, the following protocol are followed: 

a. SCCT seeks multiple supporters whenever possible to avoid the perception that programs are tied to a specific company.

b. SCCT does not promote vendor specific technology. SCCT advocates for the base service and any appropriate technological advancements in the provision of cardiac CT services. These advancements should be adequately documented in peer reviewed clinical literature

c. SCCT may participate in joint meetings or conference calls with payers and industry stakeholders but approaches payers on behalf of the society and the profession, and not on behalf of any industry stakeholder.

d. If an industry stakeholder wishes to advocate for cardiac CT, the stakeholder may use any published SCCT documents as found on the SCCT website

e. SCCT encourages direct dialogue with industry stakeholders to learn about advances in technology or other issues of interest to industry.

f.  SCCT always advocates for the best interests of patients and the appropriate provision of cardiac CT services.

 

Conclusion

The SCCT Board of Directors believes that adherence with these guidelines and protocols will allow physicians, scientists and industry to productively collaborate in order to forward our mission while avoiding undue influence or bias from industry in the conduct of our activities.

 

Adopted by Executive Committee of the SCCT Board of Directors Sept. 7, 2018

 
703-766-1706

1201 Wilson Boulevard
Arlington, VA 22209